U.S. Markets open in 6 hrs 31 mins

GlaxoSmithKline plc (GSK.L)


LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
1,629.50-12.50 (-0.76%)
At close: 5:07PM BST
Interactive chart
Previous Close1,642.00
Open1,637.00
Bid1,622.00 x 175400
Ask1,645.00 x 417900
Day's Range1,626.50 - 1,659.52
52 Week Range1,363.00 - 1,745.56
Volume10,220,320
Avg. Volume8,991,946
Market Cap79.61B
Beta1.18
PE Ratio (TTM)47.79
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.01 (4.77%)
Ex-Dividend Date2017-02-23
1y Target EstN/A
  • Reuters19 hours ago

    UK competition watchdog accuses Merck of obstructing biosimilars

    Britain's competition watchdog has accused Merck & Co of operating an unfair discount scheme for its medicine Remicade that it said was designed to restrict competition from so-called biosimilar copies. The Competition and Markets Authority (CMA) said on Tuesday it had provisionally found the U.S. company's European unit, Merck Sharp & Dohme, had abused its dominant position through the scheme, opening it up to potential financial penalties.

  • Better Buy: Celldex Therapeutics, Inc. vs. Agenus Inc.
    Motley Fool3 days ago

    Better Buy: Celldex Therapeutics, Inc. vs. Agenus Inc.

    Celldex Therapeutics and Agenus have promising oncology pipelines, but which is the better stock right now?

  • Ionis (IONS) Stock Falls Despite Positive Inotersen Data
    Zacks7 days ago

    Ionis (IONS) Stock Falls Despite Positive Inotersen Data

    Ionis Pharmaceuticals, Inc. (IONS) announced that the phase III study NEURO-TTR on inotersen (IONIS-TTRRx) in patients with familial amyloid polyneuropathy (FAP) met both primary endpoints.